Company

Advancell - Advanced In Vitro Cell

As of the edition of 20 October 2026, Advancell - Advanced In Vitro Cell runs 2 drugs; it is on route A at 2 targets and on route B at 0 targets.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

Route A at 2 targets, route B at 0 targets.

Three of its 2 rows, by target and route
Target	Route
PRKAA2 5'-AMP-activated protein kinase catalytic subunit alpha-2	Route A
PRKAA1 5'-AMP-activated protein kinase catalytic subunit alpha-1	Route A

In the product

2 company-target rows on route A or B; 0 are not shown here, and no score is.